002365 On Other Exchanges
Symbol
Exchange
Shenzhen

Transactions by QIANJIANG YONGAN PHARM-A (002365) in the last 6 months

Announced 03/2/19
33.00M for Hubei Ling'an Technology Co., Ltd.
Private Placement

Hubei Ling'an Technology Co., Ltd. announced a private placement of common shares for gross proceeds of CNY 33,330,000 on March 2, 2019. The transaction involved participation from existing investor Qianjiang Yongan Pharmaceutical Co., Ltd. (SZSE:002365) for CNY 16,931,600, Zhang Yong for CNY 13,248,800, Xia Changpei for CNY 2,266,400 and Dai Liang for CNY 883,200. Post the transaction, the registered capital of the company will increase from CNY 16,670,000 to CNY 50,000,000 ...
Read More


002365's price was unchanged after the transaction was announced on 03/2/19.
Investor / Buyer
Qianjiang Yongan Pharmaceutical Co., Ltd.
 
Announced 02/13/19
50.00M for Qianjiang Yongan Pharmaceutical Co., Ltd.
Buyback

Qianjiang Yongan Pharmaceutical Co., Ltd. (SZSE:002365) announces a share repurchase program. Under the program, the company will repurchase up to CNY 50 million worth of its class A shares. The shares will be repurchased at a price not more than CNY 15.70 per share. The repurchases will be funded using company's own funds. The shares repurchased will be used for ESOP or equity incentive plan. The program will be valid for 12 months. The Board of Directors of Qianjiang ...
Read More


002365's price was unchanged after the transaction was announced on 02/13/19.
 
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

002365 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002365.
View Industry Companies
 

Industry Analysis

002365

Industry Average

Valuation 002365 Industry Range
Price/Earnings 17.9x
Price/Sales 2.4x
Price/Book 1.6x
Price/Cash Flow 18.2x
TEV/Sales 2.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact QIANJIANG YONGAN PHARM-A, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.